Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin
- PMID: 22794249
- PMCID: PMC3447992
- DOI: 10.1021/bi3006835
Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin
Abstract
Cardiac α-tropomyosin (Tm) single-site mutations D175N and E180G cause familial hypertrophic cardiomyopathy (FHC). Previous studies have shown that these mutations increase both Ca(2+) sensitivity and residual contractile activity at low Ca(2+) concentrations, which causes incomplete relaxation during diastole resulting in hypertrophy and sarcomeric disarray. However, the molecular basis for the cause and the difference in the severity of the manifested phenotypes of disease are not known. In this work we have (1) used ATPase studies using reconstituted thin filaments in solution to show that these FHC mutants result in an increase in Ca(2+) sensitivity and an increased residual level of ATPase, (2) shown that both FHC mutants increase the rate of cleavage at R133, ~45 residues N-terminal to the mutations, when free and bound to actin, (3) shown that for Tm-E180G, the increase in the rate of cleavage is greater than that for D175N, and (4) shown that for E180G, cleavage also occurs at a new site 53 residues C-terminal to E180G, in parallel with cleavage at R133. The long-range decreases in dynamic stability due to these two single-site mutations suggest increases in flexibility that may weaken the ability of Tm to inhibit activity at low Ca(2+) concentrations for D175N and to a greater degree for E180G, which may contribute to differences in the severity of FHC.
Figures






Similar articles
-
Facilitated cross-bridge interactions with thin filaments by familial hypertrophic cardiomyopathy mutations in α-tropomyosin.J Biomed Biotechnol. 2011;2011:435271. doi: 10.1155/2011/435271. Epub 2011 Dec 1. J Biomed Biotechnol. 2011. PMID: 22187526 Free PMC article.
-
Effects of two familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin.Biophys J. 2004 Dec;87(6):3922-33. doi: 10.1529/biophysj.104.048793. Epub 2004 Sep 28. Biophys J. 2004. PMID: 15454401 Free PMC article.
-
The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy.Biochem Biophys Res Commun. 2012 Aug 3;424(3):493-6. doi: 10.1016/j.bbrc.2012.06.141. Epub 2012 Jul 9. Biochem Biophys Res Commun. 2012. PMID: 22789852 Free PMC article.
-
Cardiomyopathy-associated mutations in tropomyosin differently affect actin-myosin interaction at single-molecule and ensemble levels.J Muscle Res Cell Motil. 2019 Dec;40(3-4):299-308. doi: 10.1007/s10974-019-09560-8. Epub 2019 Oct 23. J Muscle Res Cell Motil. 2019. PMID: 31643006 Review.
-
Vertebrate tropomyosin: distribution, properties and function.J Muscle Res Cell Motil. 2001;22(1):5-49. doi: 10.1023/a:1010303732441. J Muscle Res Cell Motil. 2001. PMID: 11563548 Review.
Cited by
-
Structural and Dynamic Properties of Allergen and Non-Allergen Forms of Tropomyosin.Structure. 2018 Jul 3;26(7):997-1006.e5. doi: 10.1016/j.str.2018.05.002. Epub 2018 Jun 7. Structure. 2018. PMID: 29887498 Free PMC article.
-
N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.Am J Physiol Heart Circ Physiol. 2015 Nov 15;309(10):H1720-30. doi: 10.1152/ajpheart.00339.2015. Epub 2015 Oct 2. Am J Physiol Heart Circ Physiol. 2015. PMID: 26432840 Free PMC article.
-
Functional and Structural Properties of Cytoplasmic Tropomyosin Isoforms Tpm1.8 and Tpm1.9.Int J Mol Sci. 2024 Jun 22;25(13):6873. doi: 10.3390/ijms25136873. Int J Mol Sci. 2024. PMID: 38999987 Free PMC article.
-
Gestalt-binding of tropomyosin on actin during thin filament activation.J Muscle Res Cell Motil. 2013 Aug;34(3-4):155-63. doi: 10.1007/s10974-013-9342-0. Epub 2013 May 12. J Muscle Res Cell Motil. 2013. PMID: 23666668 Free PMC article. Review.
-
Investigating the effects of tropomyosin mutations on its flexibility and interactions with filamentous actin using molecular dynamics simulation.J Muscle Res Cell Motil. 2016 Oct;37(4-5):131-147. doi: 10.1007/s10974-016-9447-3. Epub 2016 Jul 4. J Muscle Res Cell Motil. 2016. PMID: 27376658
References
-
- Watkins H, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet. 1995;4 Spec No:1721–1727. - PubMed
-
- Tardiff JC. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev. 2005;10:237–248. - PubMed
-
- Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res. 1999;44:20–36. - PubMed
-
- Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy. Cell. 1994;77:701–712. - PubMed
-
- Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi-Takihara K. Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1995;27:2053–2058. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous